Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Current Issues in Molecular Biology|January 30, 2026
Advancing Drug Repurposing for Rheumatoid Arthritis: Integrating Protein-Protein Interaction, Molecular Docking, and Dynamics Simulations for Targeted Therapeutic ApproachesKrishna Swaroop Akey, Bharat Kumar Reddy Sanapalli, Dilep Kumar Sigalapalli, et al.
Chemistry & Biodiversity|January 8, 2026
Quorum-Sensing Inhibitors as Potential Antibacterial Agents Against Staphylococcus aureus: A Comprehensive ReviewShrestha Palit, Bharat Kumar Reddy Sanapalli, Sharon Blessy Manda, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and Clinical TranslationBharat Kumar Reddy Sanapalli, Shrestha Palit, Ashwini Deshpande, et al.
International Journal of Molecular Sciences|July 28, 2026
Integrated Network Pharmacology and Molecular Dynamics Reveal Luteolin from Persea americana as a Multi-Cancer SRC/GSK3β InhibitorAkey Krishna Swaroop, Bharat Kumar Reddy Sanapalli, Jubie Selvaraj, et al.
ACS Omega|February 10, 2025
Computational Elucidation of Human β-Defensin-2 as a Dual Inhibitor of MMP-9 and PKC-βII for Diabetic Wound ManagementVidyasrilekha Sanapalli, Dilep Kumar Sigalapalli, Afzal B Shaik, et al.
Cell Biochemistry and Function|January 21, 2026
Bruton's Tyrosine Kinase: Pathophysiological Roles and Inhibitor-Based Therapeutic AdvancesSimhadri Goud Gundrathi, Bharat Kumar Reddy Sanapalli, Shrestha Palit, et al.
Drug Development Research|January 12, 2021
Overview of in situ gelling injectable hydrogels for diabetic woundsLavanya Mude, Bharat Kumar Reddy Sanapalli, Anoop Narayanan V, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A ReviewBharat Kumar Reddy Sanapalli, Akram Ashames, Dilep Kumar Sigalapalli, et al.
International Journal of Biological Macromolecules|February 17, 2020
HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancerMantosh Kumar Singh, Sai Kiran S S Pindiprolu, Bharat Kumar Reddy Sanapalli, et al.
Pageof 4